Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.16M Buy
5,122
+3
+0.1% +$1.2K 0.8% 35
2026
Q2
$1.85M Sell
5,119
-50
-1% -$17.1K 0.71% 35
2026
Q1
$1.82M Sell
5,169
-35
-0.7% -$12.5K 0.8% 35
2025
Q4
$1.7M Sell
5,204
-90
-2% -$28.5K 0.7% 37
2025
Q3
$1.49M Buy
5,294
+380
+8% +$110K 0.63% 39
2025
Q2
$1.37M Sell
4,914
-510
-9% -$144K 0.64% 36
2025
Q1
$1.69M Sell
5,424
-431
-7% -$127K 0.85% 29
2024
Q4
$1.53M Sell
5,855
-980
-14% -$291K 0.74% 29
2024
Q3
$2.2M Buy
6,835
+105
+2% +$34.3K 1.06% 22
2024
Q2
$2.1M Hold
6,730
– – 1.05% 22
2024
Q1
$1.91M Buy
6,730
+100
+2% +$29.3K 1.03% 26
2023
Q4
$1.91M Hold
6,630
– – 1.13% 25

Other funds holding AMGN

PFC Capital Group's AMGN Position: Q3 2026 in Review

PFC Capital Group increased its Amgen (AMGN) stake by 0.06% in Q3 2026, buying an estimated $1.2K and bringing the position to 5,122 shares worth $2.16M. The position accounts for 0.8% of the portfolio, ranked #35.

PFC Capital Group first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.2M in Q3 2024. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • PFC Capital Group held 5,122 shares of Amgen worth $2.16M as of Q3 2026.
  • PFC Capital Group bought 3 Amgen shares in Q3 2026, an estimated $1.2K.
  • Amgen made up 0.8% of PFC Capital Group's portfolio in Q3 2026, its #35 holding.
  • PFC Capital Group first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • PFC Capital Group's Amgen position peaked at $2.2M in Q3 2024.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on PFC Capital Group's 13F filing for Q3 2026, filed 6 Nov 2026.